nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.116	0.453	CbGbCtD
Disopyramide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0467	0.181	CbGbCtD
Disopyramide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0434	0.169	CbGbCtD
Disopyramide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0199	0.0775	CbGbCtD
Disopyramide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0183	0.071	CbGbCtD
Disopyramide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0124	0.0484	CbGbCtD
Disopyramide—CHRM3—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.00285	0.0386	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.00282	0.0382	CbGpPWpGaD
Disopyramide—SLC22A2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.00235	0.0318	CbGpPWpGaD
Disopyramide—SLC22A1—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.00219	0.0296	CbGpPWpGaD
Disopyramide—SCN5A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00209	0.0282	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00204	0.0276	CbGpPWpGaD
Disopyramide—SCN5A—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.00164	0.0222	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.00115	0.0156	CbGpPWpGaD
Disopyramide—Fesoterodine—ABCB1—peripheral nervous system neoplasm	0.00108	0.824	CrCbGaD
Disopyramide—KCND3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00106	0.0143	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00105	0.0143	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.00103	0.0139	CbGpPWpGaD
Disopyramide—SCN5A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00102	0.0138	CbGpPWpGaD
Disopyramide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000946	0.0128	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000943	0.0127	CbGpPWpGaD
Disopyramide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000924	0.00138	CcSEcCtD
Disopyramide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000924	0.00138	CcSEcCtD
Disopyramide—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000922	0.00138	CcSEcCtD
Disopyramide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00092	0.00138	CcSEcCtD
Disopyramide—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000912	0.00137	CcSEcCtD
Disopyramide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000912	0.00137	CcSEcCtD
Disopyramide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000909	0.00136	CcSEcCtD
Disopyramide—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000903	0.00135	CcSEcCtD
Disopyramide—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000903	0.00135	CcSEcCtD
Disopyramide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.0009	0.00135	CcSEcCtD
Disopyramide—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000899	0.00135	CcSEcCtD
Disopyramide—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000895	0.00134	CcSEcCtD
Disopyramide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000893	0.00134	CcSEcCtD
Disopyramide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000893	0.00134	CcSEcCtD
Disopyramide—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000891	0.00133	CcSEcCtD
Disopyramide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000888	0.00133	CcSEcCtD
Disopyramide—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000882	0.00132	CcSEcCtD
Disopyramide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000882	0.00132	CcSEcCtD
Disopyramide—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000881	0.00132	CcSEcCtD
Disopyramide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00088	0.00132	CcSEcCtD
Disopyramide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000879	0.00132	CcSEcCtD
Disopyramide—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000878	0.00132	CcSEcCtD
Disopyramide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000871	0.0013	CcSEcCtD
Disopyramide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00087	0.0013	CcSEcCtD
Disopyramide—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000869	0.0013	CcSEcCtD
Disopyramide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000863	0.00129	CcSEcCtD
Disopyramide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000863	0.00129	CcSEcCtD
Disopyramide—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000862	0.00129	CcSEcCtD
Disopyramide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00086	0.00129	CcSEcCtD
Disopyramide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000856	0.00128	CcSEcCtD
Disopyramide—Malaise—Etoposide—peripheral nervous system neoplasm	0.000853	0.00128	CcSEcCtD
Disopyramide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000853	0.00128	CcSEcCtD
Disopyramide—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00085	0.00127	CcSEcCtD
Disopyramide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000846	0.00127	CcSEcCtD
Disopyramide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000846	0.00127	CcSEcCtD
Disopyramide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000844	0.00126	CcSEcCtD
Disopyramide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000843	0.00126	CcSEcCtD
Disopyramide—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000838	0.00125	CcSEcCtD
Disopyramide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000837	0.00125	CcSEcCtD
Disopyramide—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000835	0.00125	CcSEcCtD
Disopyramide—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000835	0.00125	CcSEcCtD
Disopyramide—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000832	0.00125	CcSEcCtD
Disopyramide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00083	0.00124	CcSEcCtD
Disopyramide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00083	0.00124	CcSEcCtD
Disopyramide—Rash—Topotecan—peripheral nervous system neoplasm	0.00083	0.00124	CcSEcCtD
Disopyramide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000829	0.00124	CcSEcCtD
Disopyramide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000829	0.00124	CcSEcCtD
Disopyramide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000825	0.00124	CcSEcCtD
Disopyramide—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000825	0.00124	CcSEcCtD
Disopyramide—Headache—Topotecan—peripheral nervous system neoplasm	0.000824	0.00124	CcSEcCtD
Disopyramide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000823	0.00123	CcSEcCtD
Disopyramide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000823	0.00123	CcSEcCtD
Disopyramide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000822	0.00123	CcSEcCtD
Disopyramide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000822	0.00123	CcSEcCtD
Disopyramide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000822	0.00123	CcSEcCtD
Disopyramide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000819	0.00123	CcSEcCtD
Disopyramide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000819	0.00123	CcSEcCtD
Disopyramide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000818	0.00123	CcSEcCtD
Disopyramide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000818	0.00123	CcSEcCtD
Disopyramide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000815	0.00122	CcSEcCtD
Disopyramide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000815	0.00122	CcSEcCtD
Disopyramide—Pain—Vincristine—peripheral nervous system neoplasm	0.000815	0.00122	CcSEcCtD
Disopyramide—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000815	0.00122	CcSEcCtD
Disopyramide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000815	0.00122	CcSEcCtD
Disopyramide—Rash—Melphalan—peripheral nervous system neoplasm	0.000812	0.00122	CcSEcCtD
Disopyramide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000812	0.00122	CcSEcCtD
Disopyramide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000806	0.00121	CcSEcCtD
Disopyramide—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000804	0.00121	CcSEcCtD
Disopyramide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000804	0.0012	CcSEcCtD
Disopyramide—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000803	0.0109	CbGpPWpGaD
Disopyramide—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000802	0.0012	CcSEcCtD
Disopyramide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000796	0.00119	CcSEcCtD
Disopyramide—SCN5A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000789	0.0107	CbGpPWpGaD
Disopyramide—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000788	0.00118	CcSEcCtD
Disopyramide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000786	0.00118	CcSEcCtD
Disopyramide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000782	0.00117	CcSEcCtD
Disopyramide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000782	0.00117	CcSEcCtD
Disopyramide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000779	0.00117	CcSEcCtD
Disopyramide—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000777	0.00116	CcSEcCtD
Disopyramide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000775	0.00116	CcSEcCtD
Disopyramide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000775	0.00116	CcSEcCtD
Disopyramide—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000775	0.00116	CcSEcCtD
Disopyramide—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000766	0.00115	CcSEcCtD
Disopyramide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000766	0.00115	CcSEcCtD
Disopyramide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000765	0.00115	CcSEcCtD
Disopyramide—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000763	0.00114	CcSEcCtD
Disopyramide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000757	0.00113	CcSEcCtD
Disopyramide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000756	0.00113	CcSEcCtD
Disopyramide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000754	0.00113	CcSEcCtD
Disopyramide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000752	0.00113	CcSEcCtD
Disopyramide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00075	0.00112	CcSEcCtD
Disopyramide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000747	0.00112	CcSEcCtD
Disopyramide—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000744	0.00112	CcSEcCtD
Disopyramide—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000742	0.00111	CcSEcCtD
Disopyramide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000736	0.0011	CcSEcCtD
Disopyramide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000733	0.0011	CcSEcCtD
Disopyramide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00073	0.00109	CcSEcCtD
Disopyramide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000722	0.00108	CcSEcCtD
Disopyramide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000721	0.00108	CcSEcCtD
Disopyramide—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000719	0.00108	CcSEcCtD
Disopyramide—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000712	0.00107	CcSEcCtD
Disopyramide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000712	0.00107	CcSEcCtD
Disopyramide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00071	0.00106	CcSEcCtD
Disopyramide—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000709	0.00106	CcSEcCtD
Disopyramide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000703	0.00105	CcSEcCtD
Disopyramide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.0007	0.00105	CcSEcCtD
Disopyramide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000695	0.00104	CcSEcCtD
Disopyramide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000693	0.00104	CcSEcCtD
Disopyramide—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000693	0.00104	CcSEcCtD
Disopyramide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000689	0.00103	CcSEcCtD
Disopyramide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000687	0.00103	CcSEcCtD
Disopyramide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000684	0.00102	CcSEcCtD
Disopyramide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000679	0.00102	CcSEcCtD
Disopyramide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000678	0.00102	CcSEcCtD
Disopyramide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000677	0.00101	CcSEcCtD
Disopyramide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000673	0.00101	CcSEcCtD
Disopyramide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000671	0.00101	CcSEcCtD
Disopyramide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000666	0.000998	CcSEcCtD
Disopyramide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000666	0.000997	CcSEcCtD
Disopyramide—Pain—Etoposide—peripheral nervous system neoplasm	0.00066	0.000989	CcSEcCtD
Disopyramide—Constipation—Etoposide—peripheral nervous system neoplasm	0.00066	0.000989	CcSEcCtD
Disopyramide—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.000987	CcSEcCtD
Disopyramide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.000987	CcSEcCtD
Disopyramide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.00098	CcSEcCtD
Disopyramide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000652	0.000977	CcSEcCtD
Disopyramide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000651	0.000975	CcSEcCtD
Disopyramide—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000641	0.00096	CcSEcCtD
Disopyramide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000636	0.000953	CcSEcCtD
Disopyramide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000634	0.000949	CcSEcCtD
Disopyramide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000633	0.000949	CcSEcCtD
Disopyramide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00063	0.000944	CcSEcCtD
Disopyramide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000629	0.000942	CcSEcCtD
Disopyramide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000628	0.000941	CcSEcCtD
Disopyramide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000624	0.000934	CcSEcCtD
Disopyramide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000623	0.000934	CcSEcCtD
Disopyramide—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00062	0.000929	CcSEcCtD
Disopyramide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00062	0.000928	CcSEcCtD
Disopyramide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000614	0.000919	CcSEcCtD
Disopyramide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000611	0.000915	CcSEcCtD
Disopyramide—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000609	0.000913	CcSEcCtD
Disopyramide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000606	0.000908	CcSEcCtD
Disopyramide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000606	0.000908	CcSEcCtD
Disopyramide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000605	0.000906	CcSEcCtD
Disopyramide—Rash—Vincristine—peripheral nervous system neoplasm	0.000601	0.0009	CcSEcCtD
Disopyramide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000601	0.0009	CcSEcCtD
Disopyramide—Headache—Vincristine—peripheral nervous system neoplasm	0.000597	0.000895	CcSEcCtD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000588	0.00795	CbGpPWpGaD
Disopyramide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000588	0.00088	CcSEcCtD
Disopyramide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000586	0.000878	CcSEcCtD
Disopyramide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000577	0.000864	CcSEcCtD
Disopyramide—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.00086	CcSEcCtD
Disopyramide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000566	0.000848	CcSEcCtD
Disopyramide—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000564	0.000845	CcSEcCtD
Disopyramide—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000563	0.00762	CbGpPWpGaD
Disopyramide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.00084	CcSEcCtD
Disopyramide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000554	0.00083	CcSEcCtD
Disopyramide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000546	0.000818	CcSEcCtD
Disopyramide—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000544	0.000815	CcSEcCtD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000539	0.00729	CbGpPWpGaD
Disopyramide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000536	0.000803	CcSEcCtD
Disopyramide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000532	0.000796	CcSEcCtD
Disopyramide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000531	0.000795	CcSEcCtD
Disopyramide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000528	0.000792	CcSEcCtD
Disopyramide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000523	0.000783	CcSEcCtD
Disopyramide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000521	0.00078	CcSEcCtD
Disopyramide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000519	0.000778	CcSEcCtD
Disopyramide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000518	0.007	CbGpPWpGaD
Disopyramide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000515	0.000772	CcSEcCtD
Disopyramide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000511	0.000765	CcSEcCtD
Disopyramide—CHRM1—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000506	0.00684	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000504	0.00682	CbGpPWpGaD
Disopyramide—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000504	0.000754	CcSEcCtD
Disopyramide—CHRM3—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.000501	0.00677	CbGpPWpGaD
Disopyramide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000501	0.00075	CcSEcCtD
Disopyramide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.0005	0.000749	CcSEcCtD
Disopyramide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000737	CcSEcCtD
Disopyramide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000491	0.000736	CcSEcCtD
Disopyramide—Rash—Etoposide—peripheral nervous system neoplasm	0.000487	0.000729	CcSEcCtD
Disopyramide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000486	0.000729	CcSEcCtD
Disopyramide—Headache—Etoposide—peripheral nervous system neoplasm	0.000484	0.000725	CcSEcCtD
Disopyramide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000724	CcSEcCtD
Disopyramide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.000721	CcSEcCtD
Disopyramide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.00072	CcSEcCtD
Disopyramide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000478	0.000717	CcSEcCtD
Disopyramide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000714	CcSEcCtD
Disopyramide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000714	CcSEcCtD
Disopyramide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000476	0.000713	CcSEcCtD
Disopyramide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000698	CcSEcCtD
Disopyramide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.000693	CcSEcCtD
Disopyramide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000459	0.000687	CcSEcCtD
Disopyramide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000682	CcSEcCtD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000453	0.00612	CbGpPWpGaD
Disopyramide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000452	0.000676	CcSEcCtD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000451	0.0061	CbGpPWpGaD
Disopyramide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000446	0.000668	CcSEcCtD
Disopyramide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000663	CcSEcCtD
Disopyramide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000662	CcSEcCtD
Disopyramide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000661	CcSEcCtD
Disopyramide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000659	CcSEcCtD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000439	0.00594	CbGpPWpGaD
Disopyramide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000437	0.000654	CcSEcCtD
Disopyramide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000648	CcSEcCtD
Disopyramide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000646	CcSEcCtD
Disopyramide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000638	CcSEcCtD
Disopyramide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000635	CcSEcCtD
Disopyramide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00042	0.00063	CcSEcCtD
Disopyramide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000627	CcSEcCtD
Disopyramide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.000626	CcSEcCtD
Disopyramide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000618	CcSEcCtD
Disopyramide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000618	CcSEcCtD
Disopyramide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000612	CcSEcCtD
Disopyramide—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000606	CcSEcCtD
Disopyramide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000605	CcSEcCtD
Disopyramide—CHRM3—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.000403	0.00545	CbGpPWpGaD
Disopyramide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.0006	CcSEcCtD
Disopyramide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.00059	CcSEcCtD
Disopyramide—CHRM3—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.000394	0.00533	CbGpPWpGaD
Disopyramide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000588	CcSEcCtD
Disopyramide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000587	CcSEcCtD
Disopyramide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000583	CcSEcCtD
Disopyramide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000582	CcSEcCtD
Disopyramide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.00058	CcSEcCtD
Disopyramide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000578	CcSEcCtD
Disopyramide—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000385	0.00521	CbGpPWpGaD
Disopyramide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000385	0.000577	CcSEcCtD
Disopyramide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000572	CcSEcCtD
Disopyramide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000571	CcSEcCtD
Disopyramide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000564	CcSEcCtD
Disopyramide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000561	CcSEcCtD
Disopyramide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000373	0.000559	CcSEcCtD
Disopyramide—Pain—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000555	CcSEcCtD
Disopyramide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000555	CcSEcCtD
Disopyramide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000543	CcSEcCtD
Disopyramide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.000539	CcSEcCtD
Disopyramide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000535	CcSEcCtD
Disopyramide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000534	CcSEcCtD
Disopyramide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000533	CcSEcCtD
Disopyramide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000528	CcSEcCtD
Disopyramide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000522	CcSEcCtD
Disopyramide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000517	CcSEcCtD
Disopyramide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000515	CcSEcCtD
Disopyramide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000513	CcSEcCtD
Disopyramide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000513	CcSEcCtD
Disopyramide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000513	CcSEcCtD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000335	0.00453	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000334	0.00452	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000331	0.00447	CbGpPWpGaD
Disopyramide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000494	CcSEcCtD
Disopyramide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000477	CcSEcCtD
Disopyramide—CHRM3—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.000317	0.00429	CbGpPWpGaD
Disopyramide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000474	CcSEcCtD
Disopyramide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000312	0.00422	CbGpPWpGaD
Disopyramide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000465	CcSEcCtD
Disopyramide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000459	CcSEcCtD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000303	0.0041	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000301	0.00407	CbGpPWpGaD
Disopyramide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000297	0.00402	CbGpPWpGaD
Disopyramide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000444	CcSEcCtD
Disopyramide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000431	CcSEcCtD
Disopyramide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000429	CcSEcCtD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000284	0.00384	CbGpPWpGaD
Disopyramide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000425	CcSEcCtD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000278	0.00376	CbGpPWpGaD
Disopyramide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000412	CcSEcCtD
Disopyramide—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000275	0.00372	CbGpPWpGaD
Disopyramide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000411	CcSEcCtD
Disopyramide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000409	CcSEcCtD
Disopyramide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000409	CcSEcCtD
Disopyramide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000406	CcSEcCtD
Disopyramide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000397	CcSEcCtD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000265	0.00358	CbGpPWpGaD
Disopyramide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000385	CcSEcCtD
Disopyramide—CHRM1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000255	0.00345	CbGpPWpGaD
Disopyramide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000382	CcSEcCtD
Disopyramide—CHRM3—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000254	0.00344	CbGpPWpGaD
Disopyramide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000378	CcSEcCtD
Disopyramide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000378	CcSEcCtD
Disopyramide—CHRM2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000252	0.00341	CbGpPWpGaD
Disopyramide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000376	CcSEcCtD
Disopyramide—KCND3—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000248	0.00336	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000245	0.00331	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000244	0.0033	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000241	0.00327	CbGpPWpGaD
Disopyramide—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000238	0.00322	CbGpPWpGaD
Disopyramide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000356	CcSEcCtD
Disopyramide—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000238	0.00321	CbGpPWpGaD
Disopyramide—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000235	0.00318	CbGpPWpGaD
Disopyramide—Methadone—ABCB1—peripheral nervous system neoplasm	0.000231	0.176	CrCbGaD
Disopyramide—CHRM1—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.00023	0.00311	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000227	0.00307	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000227	0.00306	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000226	0.00306	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000221	0.00299	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00022	0.00297	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000219	0.00297	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000219	0.00297	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000218	0.00294	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000211	0.00285	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000205	0.00277	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000204	0.00277	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000204	0.00276	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000203	0.00275	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000203	0.00274	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000203	0.00274	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000197	0.00266	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000189	0.00255	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000187	0.00253	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	0.000184	0.00249	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.00017	0.0023	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000163	0.00221	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000151	0.00204	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00015	0.00203	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000149	0.00201	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000148	0.002	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000144	0.00195	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000144	0.00194	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000142	0.00193	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000138	0.00187	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000135	0.00182	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000131	0.00178	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000131	0.00177	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000131	0.00177	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000129	0.00175	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000128	0.00172	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000126	0.0017	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000125	0.00169	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000124	0.00168	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000124	0.00167	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000123	0.00167	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000122	0.00164	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000115	0.00155	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000114	0.00155	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000113	0.00153	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000113	0.00153	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000112	0.00151	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000109	0.00148	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000109	0.00147	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000108	0.00146	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GNS—peripheral nervous system neoplasm	0.000107	0.00145	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000104	0.00141	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—NME1—peripheral nervous system neoplasm	0.000103	0.00139	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000102	0.00139	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.0001	0.00136	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	9.99e-05	0.00135	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GNS—peripheral nervous system neoplasm	9.98e-05	0.00135	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	9.96e-05	0.00135	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	9.93e-05	0.00134	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	9.92e-05	0.00134	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	9.9e-05	0.00134	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	9.89e-05	0.00134	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—COX2—peripheral nervous system neoplasm	9.88e-05	0.00134	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	9.83e-05	0.00133	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	9.8e-05	0.00132	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	9.61e-05	0.0013	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NME1—peripheral nervous system neoplasm	9.57e-05	0.00129	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GNS—peripheral nervous system neoplasm	9.22e-05	0.00125	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—COX2—peripheral nervous system neoplasm	9.21e-05	0.00125	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.16e-05	0.00124	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.13e-05	0.00123	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.04e-05	0.00122	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.99e-05	0.00122	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NME1—peripheral nervous system neoplasm	8.84e-05	0.0012	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.82e-05	0.00119	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—COX2—peripheral nervous system neoplasm	8.51e-05	0.00115	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.37e-05	0.00113	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.22e-05	0.00111	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.74e-05	0.00105	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.71e-05	0.00104	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.64e-05	0.00103	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	7.49e-05	0.00101	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	7.43e-05	0.001	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.42e-05	0.001	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	7.41e-05	0.001	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.39e-05	0.001	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.38e-05	0.000998	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.32e-05	0.00099	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	7.31e-05	0.000988	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.67e-05	0.000902	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	6.49e-05	0.000878	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.48e-05	0.000876	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.46e-05	0.000873	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.4e-05	0.000865	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.21e-05	0.00084	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	6.05e-05	0.000818	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	6e-05	0.000811	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.88e-05	0.000796	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.87e-05	0.000793	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.86e-05	0.000793	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.84e-05	0.00079	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.81e-05	0.000785	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.79e-05	0.000783	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.67e-05	0.000766	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.65e-05	0.000764	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.59e-05	0.000756	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ENO2—peripheral nervous system neoplasm	5.59e-05	0.000756	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	5.48e-05	0.000742	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	5.44e-05	0.000735	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	5.42e-05	0.000733	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.41e-05	0.000732	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.39e-05	0.000729	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.35e-05	0.000723	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.34e-05	0.000722	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.23e-05	0.000707	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	5.16e-05	0.000697	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.15e-05	0.000696	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.13e-05	0.000694	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	5.11e-05	0.000691	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	5.11e-05	0.000691	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.08e-05	0.000687	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.99e-05	0.000674	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.88e-05	0.000659	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	4.8e-05	0.00065	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	4.76e-05	0.000644	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.72e-05	0.000638	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—BCHE—peripheral nervous system neoplasm	4.72e-05	0.000638	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.5e-05	0.000609	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—TH—peripheral nervous system neoplasm	4.44e-05	0.0006	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.21e-05	0.000569	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.13e-05	0.000558	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.06e-05	0.00055	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.05e-05	0.000548	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.01e-05	0.000542	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	3.92e-05	0.00053	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.85e-05	0.000521	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GNAS—peripheral nervous system neoplasm	3.62e-05	0.00049	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	3.6e-05	0.000488	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.58e-05	0.000484	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.56e-05	0.000482	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ABCB1—peripheral nervous system neoplasm	3.56e-05	0.000481	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.53e-05	0.000477	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.48e-05	0.00047	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.46e-05	0.000469	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.46e-05	0.000467	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.43e-05	0.000464	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	3.33e-05	0.00045	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.31e-05	0.000448	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.3e-05	0.000447	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.27e-05	0.000442	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.04e-05	0.000411	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.03e-05	0.00041	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3e-05	0.000406	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.18e-05	0.000295	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.15e-05	0.000291	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.14e-05	0.00029	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.12e-05	0.000287	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.11e-05	0.000286	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.11e-05	0.000285	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.09e-05	0.000282	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.85e-05	0.00025	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.76e-05	0.000238	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.74e-05	0.000235	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.67e-05	0.000226	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.66e-05	0.000225	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.65e-05	0.000223	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.57e-05	0.000213	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.57e-05	0.000212	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.55e-05	0.00021	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.53e-05	0.000207	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.52e-05	0.000206	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.52e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.51e-05	0.000204	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.51e-05	0.000204	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.5e-05	0.000202	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.42e-05	0.000192	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.39e-05	0.000188	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.39e-05	0.000188	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.38e-05	0.000187	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.37e-05	0.000185	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.27e-05	0.000172	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.27e-05	0.000171	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.25e-05	0.00017	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.18e-05	0.00016	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.18e-05	0.000159	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.17e-05	0.000158	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.14e-05	0.000154	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.06e-05	0.000143	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	9.78e-06	0.000132	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.72e-06	0.000131	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.68e-06	0.000131	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.59e-06	0.00013	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.29e-06	0.000126	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.26e-06	0.000125	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.17e-06	0.000124	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.2e-06	0.000111	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.18e-06	0.000111	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.1e-06	0.00011	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.82e-06	5.17e-05	CbGpPWpGaD
